drugset / Trial / NCT00532311
Efficacy of Lapaquistat Acetate Co-Administered With Statins in Subjects With Hypercholesterolemia
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of the study is to determine the efficacy of lapaquistat acetate, once daily (QD), taken with statins on cholesterol levels in subjects with hypercholesterolemia
Timeline
- Start
- 2007-07
- Primary completion
- 2008-04
- Completion
- 2008-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lapaquistat acetate | Small molecule | 50 mg | Oral |
| Comparator | Atorvastatin | Small molecule | — | Oral |
| Comparator | Fluvastatin | Other / unclassified | — | Oral |
| Comparator | Lovastatin | Small molecule | — | Oral |
| Comparator | Pravastatin | Small molecule | — | Oral |
| Comparator | Rosuvastatin | Small molecule | — | Oral |
| Comparator | Simvastatin | Small molecule | — | Oral |